PETACH TIKVA, Israel, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (Nasdaq: NNOX), (“Nano-X” or the “Company”) an innovative medical imaging technology company, today announced that it has entered into a securities purchase agreement with a single long-term institutional investor for the purchase and sale of 8,000,000 Ordinary Shares (or prefunded warrants in lieu of any portion thereo...
New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its potential role in supporting guideline-directed preventive care.
PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2026, and provided a business update. Recent Highlights: Generated $4.3 million in revenue in the first quarter of 2026, compared to $2.8 million in the first quarter ...
Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Top Med SAC (“Top Med”) to deploy the Nanox.ARC system and related services in Peru.
NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.
NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces it is investigating claims on behalf of investors of Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX). The investigation concerns whether Nano-X and certain officers and/or directors have engaged in securities fraud or other unlawful business practices.
Advances Nanox's ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has signed a distribution agreement with NuvioDx LLC (“NuvioDx”), an imaging solutions pro...